Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antiviral_drug
gptkb:drug |
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alternativeName |
gptkb:Acelarin
|
| gptkbp:CASNumber |
1626780-59-4
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:NuCana
|
| gptkbp:hasMolecularFormula |
C15H19F2N3O6P
|
| gptkbp:investigatedBy |
gptkb:biliary_tract_cancer
gptkb:cancer pancreatic cancer |
| gptkbp:mechanismOfAction |
nucleoside analog inhibitor
targets DNA synthesis |
| gptkbp:relatedTo |
gemcitabine
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:Acelarin
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
NUC-1031
|